Literature DB >> 4345622

Ampicillin and hetacillin pharmacokinetics in normal and anephric subjects.

W J Jusko, G P Lewis, G W Schmitt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4345622     DOI: 10.1002/cpt197314190

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  21 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.

Authors:  R A Blum; R K Kohli; N J Harrison; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

3.  Effect of pH and human serum on the susceptibility of group D streptococci (Enterococci) to ampicillin in vitro.

Authors:  D N Gilbert; N Eubanks
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

4.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

Review 5.  Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications.

Authors:  W A Craig; P G Welling
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 6.  Pharmacokinetics and pharmacodynamics in critically ill patients.

Authors:  H J Mann; D W Fuhs; F B Cerra
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

Review 7.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

8.  Pharmacokinetics of gentamicin and kanamycin during hemodialysis.

Authors:  M Danish; R Schultz; W J Jusko
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

9.  Mecillinam in patients on haemodialysis.

Authors:  K Bailey; J G Cruickshank; P G Bisson; B L Radford
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

10.  Human pharmacokinetics and disposition of sarmoxicillin, a lipophilic amoxicillin prodrug.

Authors:  R D Smyth; M Pfeffer; D R Van Harken; A Cohen; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.